EDUCATION & RESEARCH

Dr Arla Ogilvie

Dr Ogilvie is committed to continuing professional development and lifelong learning. More importantly she is a devoted teacher, always willing to share her knowledge and expertise. Over the years, she has been mentor, guide and tutor to many doctors, nurses, medical students and other healthcare professionals. She has delivered numerous clinical and educational presentations at national and international meetings.

Throughout her career Dr Ogilvie has maintained a keen and active interest in medical education and research. In 2007 she completed the 2 year part-time programme through the Royal College of Physicians: Physicians as Educators

INTERNAL MEDICINE

DIABETES

ENDOCRINOLOGY

Educational roles include:

  • Professor of Medicine and Chair of the UK Clinical Programme, St George’s International School of Medicine (2012 – 2019)
  • Honorary Clinical Lecturer, University College London Medical School (2005 – 2013)
  • Postgraduate MRCP examiner, Royal College of Physicians, UK (2003 – present)
  • Examiner final medical examinations University College London & St George’s University (2004 – 2018)
  • Educational Supervisor to medical students and junior doctors (2012 – 2019)
  • Undergraduate Lead for West Hertfordshire Hospitals Trust (2002 – 2013)
  • Foundation Training Programme Director at Watford General Hospital. Set up the Foundation Training Programme for junior doctors (2004 – 2009)
  • Director of Medical Education (Watford), St George’s International School of Medicine (2011 – 2017)
  • Deputy Clinical Tutor (postgraduate education) for West Hertfordshire Hospitals Trust (2013 – 2016)
  • UK Clinical Council Executive Committee, St George’s University (2012 – 2019)
  • Joint Executive Committee of the Faculty Senate, St George’s University (2015 – 2017)
  • Final Clinical Competence Examination Committee, St George’s University (2014 – 18)
  • Clinical Committee for Academic Progress, St George’s University (2013 – 2018)

Research
Selected Publications and Presentations:

Christopher JG Kelly, Arla Ogilvie, John R Evans, David Shapiro, A Michael Wallace, David L Davies. Raised Cortisol Excretion in Urine and Contamination by Topical Steroids. British Medical Journal, 322:594, 10 Mar 2001

A Ogilvie, B Ratanjee, C Clarke-Gray, AD Marais, J Brink. An Unusual HDL Response in Cardiac Transplant Patients in the Early Postoperative Period. Oral Presentation to Lipid Association of South Africa. March 1996.

A Ogilvie, S Soule, BH Ascott-Evans, NS Levitt, F Bonnici. Comparison of High and Low Dose Carbimazole Regimes in the Treatment of Graves’ Thyrotoxicosis.

Oral Presentation to Society for Endocrinology, Metabolism and Diabetes of Southern Africa. March 1996

A Ogilvie, B Ratanjee, AD Marais. An Unusual Case of Hyperalphalipoproteinaemia. Oral Presentation to Lipid Association of South Africa.  March 1994.

B Ratanjee, A Ogilvie, AD Marais. Probucol Therapy Reduces the Concentration of a Large HDL Species in a Patient with Hyperalphalipoproteinaemia. Oral Presentation to Lipid Association of South Africa.  March 1994.

Pre-meal Insulin lispro mid Mixture plus NPH at Bedtime versus Premeal      Regular human Insulin plus NPH at bedtime in patients with Type 1 Diabetes.

Protocol F3Z-MC-IOGT (co-investigator) – Multicentre Eli Lilly – 1997/8

Dose Response Relationship [of Five Dose levels of NNC90-1170 and Placebo on Glycaemic Control in Type 2 Diabetic Patients Compared to OHA Treatment

(Principal Investigator) – Multicentre NovoNordisk – 2001

Conrad Smith, Tracy Lester, Arla Ogilvie, Peter Risby, Cassie Frase- Jones and Anneke Seller.   RNA analysis of potential splicing mutations in the diagnostic laboratory.

Oral presentations to Molecular Genetics Society Conference 2006

Sam AH, Salem V. Ogilvie AJ, Patel B, Clements MR. “A Big deal” Case report of patient with severe hypoglycaemia due to Big IGF2 production from a haemangiopericytoma. Poster presentation at Clinical Cases meeting Royal Society of Medicine 2008

Valsalakumari PC, Ogilvie AJ, Kong C “Therapeutic Role of Dopamine Agonists in ESRF induced Hyperprolactinaemia” Case Reports and Literature review

Poster presentation to 15th Clinicopathological Pituitary Conference, London 2013 and to European Congress of Endocrinology 2013

P Valsalakumari , A Ogilvie “ Hypoglycaemia care pathway for admission avoidance. A partnership approach with local ambulance trust and community diabetes team”

Poster presentation to Diabetes UK Annual Professional Conference 2015

Bernard Freudenthal, Daniel Beder, Arla Ogilvie “Case Series of short synacthen tests supports using 9am cortisol level to exclude adrenal insufficiency”

Clinical letter; Clinical Medicine Feb 2016

NN924-4221 (PIONEER 6) Study of oral Semaglutide – A multi-centre international randomised cardiovascular outcomes trial (Co-Investigator) 2016-18

Kleopatra Alexandriou, Devesenan Devendra, Thomas Galliford, Martina Owens, Anne- Marie Russell, Nizar Damani, Arla Ogilvie “A Rare Case of MEN4 presenting with Hypercalcaemia in a patient with Microprolactinoma 6 years after Diagnosis”

Poster presentation to the British Endocrine Society Meeting Nov 17

Pedro marques, Sayka Barry, Amy Ronaldson, Arla Ogilvie, Helen Storr, Peter Goadsby, Michael Powell, Mary Dang, Harvinder Chahal, Jane Evanson, Ajith Kumar,Joan Grieve, Marta Korbonits “Emergence of Pituitary Adenoma in a child during surveillance – Clinical Challenges and the family members’ view in an AIP mutation positive family”

International Journal of Endocrinology 2018(3) 1-15